On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Boehringer Ingelheim (Japan)

InstitutionResearch output, impact & collaborations

Boehringer Ingelheim (Japan) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Boehringer Ingelheim (Japan)?

ScholarIQrecord summary

Boehringer Ingelheim (Japan) is a research organisation in Tokyo, JP. OpenAlex records 1,025 works and 87,040 citations for it. 296 researchers list it as their most recent affiliation.

How many works does Boehringer Ingelheim (Japan) have?

ScholarIQindexed works

Boehringer Ingelheim (Japan) has 1,025 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Boehringer Ingelheim (Japan) →

How many citations does Boehringer Ingelheim (Japan) have?

ScholarIQcitation count

Boehringer Ingelheim (Japan) has 87,040 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Boehringer Ingelheim (Japan) →

How many researchers are at Boehringer Ingelheim (Japan)?

ScholarIQresearcher count

Boehringer Ingelheim (Japan) has 296 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Boehringer Ingelheim (Japan)?

ScholarIQavg h-index

Boehringer Ingelheim (Japan) has an average h-index of 2 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Boehringer Ingelheim (Japan)?

ScholarIQror

The ROR for Boehringer Ingelheim (Japan) is on the source record.

Open the ROR →

What is the OpenAlex record for Boehringer Ingelheim (Japan)?

ScholarIQopenalex

The OpenAlex for Boehringer Ingelheim (Japan) is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Boehringer Ingelheim (Japan)?

ScholarIQtop researchers by citations

Satabdi Chatterjee · Chronic Kidney Disease and Diabetes

11 works43 citations

What are the most-cited papers on Boehringer Ingelheim (Japan)?

ScholarIQmost cited works

The Bidirectional Association of Chronic Kidney Disease, Type 2 Diabetes, Atherosclerotic Cardiovascular Disease, and Heart Failure: The Cardio–Renal–Metabolic Syndrome

Gregory A. Nichols, Efrat L. Amitay, Satabdi Chatterjee, Dominik Steubl

Metabolic Syndrome and Related Disorders. 202327 Citations

Health Care Costs Associated with the Development and Combination of Cardio-Renal-Metabolic Diseases

Gregory A. Nichols, Efrat L. Amitay, Satabdi Chatterjee, Dominik Steubl

Kidney360. 202316 CitationsOPEN ACCESS

HSD80 Evaluation of Methotrexate Based Combinations in Rheumatoid Arthritis Patients: Results from a U.S. Administrative Claims Database

Yuying Huang, Shreya Agarwal, H Chen, Magnus L. Johnson, Satabdi Chatterjee, RR Aparasu

Value in Health. 20220 CitationsOPEN ACCESS

HSD133 Factors Influencing Selection of First Add-on Disease-Modifying Therapy for Rheumatoid Arthritis after Starting Methotrexate

Yixuan Huang, Suneal Agarwal, H Chen, Magnus L. Johnson, Satabdi Chatterjee, RR Aparasu

Value in Health. 20220 Citations

The Effect of Cardiometabolic Comorbidities on Risk of Chronic Kidney Disease Incidence: A Longitudinal Cohort Study

Gregory A. Nichols, Moe H. Kyaw, Satabdi Chatterjee, Dominik Steubl, Assad Jaghutriz Benjamin

Diabetologie und Stoffwechsel. 20220 Citations

How much of the research on Boehringer Ingelheim (Japan) is open access?

ScholarIQopen access share

40%OPEN ACCESS

Gold

30%

Green

Hybrid

Bronze

10%

Closed

60%